Kollmannsberger C - Search Results

1

A Phase II Study of PX-866 in Patients With Recurrent or Metastatic Castration-resistant Prostate Cancer: Canadian Cancer Trials Group Study IND205.

Hotte SJ, Chi KN, Joshua AM, Tu D, Macfarlane RJ, Gregg RW, Ruether JD, Basappa NS, Finch D, Salim M, Winquist EW, Torri V, North S, Kollmannsberger C, Ellard SL, Eigl BJ, Tinker A, Allan AL, Beja K, Annala M, Powers J, Wyatt AW, Seymour L; Canadian Cancer Trials Group (formerly NCIC Clinical Trials Group). Hotte SJ, et al. Among authors: kollmannsberger c. Clin Genitourin Cancer. 2019 Jun;17(3):201-208.e1. doi: 10.1016/j.clgc.2019.03.005. Epub 2019 Mar 15. Clin Genitourin Cancer. 2019. PMID: 31056399 Clinical Trial.

2

Minimizing treatment without compromising cure with primary surveillance for clinical stage I embryonal predominant nonseminomatous testicular cancer: a population based analysis from British Columbia.

Al-Tourah AJ, Murray N, Coppin C, Kollmannsberger C, Man A, Chi KN. Al-Tourah AJ, et al. Among authors: kollmannsberger c. J Urol. 2005 Dec;174(6):2209-13, discussion 2213. doi: 10.1097/01.ju.0000181810.22617.f8. J Urol. 2005. PMID: 16280765

3

First- and second-line chemotherapy with docetaxel or mitoxantrone in patients with hormone-refractory prostate cancer: does sequence matter?

Michels J, Montemurro T, Murray N, Kollmannsberger C, Nguyen Chi K. Michels J, et al. Among authors: kollmannsberger c. Cancer. 2006 Mar 1;106(5):1041-6. doi: 10.1002/cncr.21695. Cancer. 2006. PMID: 16456811 Free article. Clinical Trial.

4

Recent advances in management of patients with platinum-refractory testicular germ cell tumors.

Kollmannsberger C, Nichols C, Bokemeyer C. Kollmannsberger C, et al. Cancer. 2006 Mar 15;106(6):1217-26. doi: 10.1002/cncr.21742. Cancer. 2006. PMID: 16463389 Free article. Review.

5

Phase II study of Triapine in patients with metastatic renal cell carcinoma: a trial of the National Cancer Institute of Canada Clinical Trials Group (NCIC IND.161).

Knox JJ, Hotte SJ, Kollmannsberger C, Winquist E, Fisher B, Eisenhauer EA. Knox JJ, et al. Among authors: kollmannsberger c. Invest New Drugs. 2007 Oct;25(5):471-7. doi: 10.1007/s10637-007-9044-9. Epub 2007 Mar 28. Invest New Drugs. 2007. PMID: 17393073 Clinical Trial.

6

A population-based study evaluating the impact of sunitinib on overall survival in the treatment of patients with metastatic renal cell cancer.

Heng DY, Chi KN, Murray N, Jin T, Garcia JA, Bukowski RM, Rini BI, Kollmannsberger C. Heng DY, et al. Among authors: kollmannsberger c. Cancer. 2009 Feb 15;115(4):776-83. doi: 10.1002/cncr.24051. Cancer. 2009. PMID: 19127560 Free article.

7

A phase IB study of ABT-751 in combination with docetaxel in patients with advanced castration-resistant prostate cancer.

Michels J, Ellard SL, Le L, Kollmannsberger C, Murray N, Tomlinson Guns ES, Carr R, Chi KN. Michels J, et al. Among authors: kollmannsberger c. Ann Oncol. 2010 Feb;21(2):305-311. doi: 10.1093/annonc/mdp311. Epub 2009 Jul 24. Ann Oncol. 2010. PMID: 19633045 Free article. Clinical Trial.

8

Prognostic factors for overall survival in patients with metastatic renal cell carcinoma treated with vascular endothelial growth factor-targeted agents: results from a large, multicenter study.

Heng DY, Xie W, Regan MM, Warren MA, Golshayan AR, Sahi C, Eigl BJ, Ruether JD, Cheng T, North S, Venner P, Knox JJ, Chi KN, Kollmannsberger C, McDermott DF, Oh WK, Atkins MB, Bukowski RM, Rini BI, Choueiri TK. Heng DY, et al. Among authors: kollmannsberger c. J Clin Oncol. 2009 Dec 1;27(34):5794-9. doi: 10.1200/JCO.2008.21.4809. Epub 2009 Oct 13. J Clin Oncol. 2009. PMID: 19826129

9

Non-risk-adapted surveillance for patients with stage I nonseminomatous testicular germ-cell tumors: diminishing treatment-related morbidity while maintaining efficacy.

Kollmannsberger C, Moore C, Chi KN, Murray N, Daneshmand S, Gleave M, Hayes-Lattin B, Nichols CR. Kollmannsberger C, et al. Ann Oncol. 2010 Jun;21(6):1296-1301. doi: 10.1093/annonc/mdp473. Epub 2009 Oct 29. Ann Oncol. 2010. PMID: 19875756 Free article.

10

Management of disseminated nonseminomatous germ cell tumors with risk-based chemotherapy followed by response-guided postchemotherapy surgery.

Kollmannsberger C, Daneshmand S, So A, Chi KN, Murray N, Moore C, Hayes-Lattin B, Nichols C. Kollmannsberger C, et al. J Clin Oncol. 2010 Feb 1;28(4):537-42. doi: 10.1200/JCO.2009.23.0755. Epub 2009 Dec 21. J Clin Oncol. 2010. PMID: 20026807

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

303 results

Search Page

Filters